Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy E Welty

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmacy Practice|April 11, 2022
Suboptimal Dosing of Benzodiazepines and Levetiracetam in a Cohort of Status Epilepticus Patients and Outcomes Associated with Inadequate DosingKristina R M Braun, L Lisa Pham, Geoffrey C Wall, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|July 27, 2022
Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medicationsAli A Asadi-Pooya, Archana A Patel, Eugen Trinka, et al.
Epilepsy Currents|November 14, 2024
The Fundamentals of Antiseizure Medications: A Through ZTimothy E Welty, Jeannine M Conway, Jacquelyn Bainbridge, et al.
Epilepsy & Behavior : E&B|January 25, 2021
Coffee and cigarette smoking interactions with lamotrigineTimothy E Welty, Barry E Gidal, Jiawei Duan, et al.
Epilepsia Open|February 6, 2022
Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task ForceJenna Niyongere, Timothy E Welty, Michelle W Bell, et al.
Pharmacotherapy|August 28, 2010
The essential research curriculum for doctor of pharmacy degree programs, Mary W Lee, Patrick G Clay, et al.
The Lancet. Neurology|February 16, 2016
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trialMichael D Privitera, Timothy E Welty, Barry E Gidal, et al.
JAMA Neurology|June 28, 2017
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical TrialMichel Berg, Timothy E Welty, Barry E Gidal, et al.
Epilepsy Currents|August 22, 2020
Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments CommitteeDavid G Vossler, Jacquelyn L Bainbridge, Jane G Boggs, et al.
Epilepsy Currents|June 12, 2025
American Epilepsy Society/International League Against Epilepsy-North America Joint Task Force for Epilepsy Health Care Disparities in the United StatesJaideep Kapur, Dave Clarke, Mill Etienne, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Pharmacy Practice|April 11, 2022
Suboptimal Dosing of Benzodiazepines and Levetiracetam in a Cohort of Status Epilepticus Patients and Outcomes Associated with Inadequate DosingKristina R M Braun, L Lisa Pham, Geoffrey C Wall, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|July 27, 2022
Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medicationsAli A Asadi-Pooya, Archana A Patel, Eugen Trinka, et al.
Epilepsy Currents|November 14, 2024
The Fundamentals of Antiseizure Medications: A Through ZTimothy E Welty, Jeannine M Conway, Jacquelyn Bainbridge, et al.
Epilepsy & Behavior : E&B|January 25, 2021
Coffee and cigarette smoking interactions with lamotrigineTimothy E Welty, Barry E Gidal, Jiawei Duan, et al.
Epilepsia Open|February 6, 2022
Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task ForceJenna Niyongere, Timothy E Welty, Michelle W Bell, et al.
Pharmacotherapy|August 28, 2010
The essential research curriculum for doctor of pharmacy degree programs, Mary W Lee, Patrick G Clay, et al.
The Lancet. Neurology|February 16, 2016
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trialMichael D Privitera, Timothy E Welty, Barry E Gidal, et al.
JAMA Neurology|June 28, 2017
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical TrialMichel Berg, Timothy E Welty, Barry E Gidal, et al.
Epilepsy Currents|August 22, 2020
Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments CommitteeDavid G Vossler, Jacquelyn L Bainbridge, Jane G Boggs, et al.
Epilepsy Currents|June 12, 2025
American Epilepsy Society/International League Against Epilepsy-North America Joint Task Force for Epilepsy Health Care Disparities in the United StatesJaideep Kapur, Dave Clarke, Mill Etienne, et al.
Pageof 2